Clinical trials often seek to determine the equivalence, non-inferiority, or superiority of an experimental condition (e.g., a new drug) compared to a control condition (e.g., a placebo or an already existing drug). The use of frequentist statistical methods to analyze data for these types of designs is ubiquitous. Importantly, however, frequentist inference has several limitations. Bayesian inference remedies these shortcomings and allows for intuitive interpretations. In this article, we outline the frequentist conceptualization of equivalence, non-inferiority, and superiority designs and discuss its disadvantages. Subsequently, we explain how Bayes factors can be used to compare the relative plausibility of competing hypotheses. We prese...
This perspective is a companion to a recent editorial on the use of Bayesian analysis in clinical re...
There have been considerable methodological developments of Bayes factors for hypothesis testing in ...
RATIONALEBedside use of Bayes' theorem for estimating probabilities of diseases is cumbersome. An al...
Clinical trials often seek to determine the superiority, equivalence, or non-inferiority of an exper...
Clinical trials often seek to determine the superiority, equivalence, or non-inferiority of an exper...
Abstract Background Clinical trials often seek to determine the superiority, equivalence, or non-inf...
BACKGROUND: In clinical trials, study designs may focus on assessment of superiority, equivalence, o...
Non-inferiority trials, which aim to demonstrate that a test product is not worse than a competitor ...
Medical research makes intensive use of statistics in order to support its claims. In this paper we ...
In this article, we consider three-arm noninferiority (NI) trial that includes an experimental, a re...
In non-inferiority trials, the goal is to show how an experimental treatment is statistically and cl...
Background and aims: It has been proposed that more use should be made of Bayes factors in hypothesi...
Inference using significance testing and Bayes factors is compared and contrasted in five case studi...
BackgroundUntil recently a typical rule that has often been used for the endorsement of new medicati...
In frequentist tests, the significance testing framework for null hypothesis permits dichotomous con...
This perspective is a companion to a recent editorial on the use of Bayesian analysis in clinical re...
There have been considerable methodological developments of Bayes factors for hypothesis testing in ...
RATIONALEBedside use of Bayes' theorem for estimating probabilities of diseases is cumbersome. An al...
Clinical trials often seek to determine the superiority, equivalence, or non-inferiority of an exper...
Clinical trials often seek to determine the superiority, equivalence, or non-inferiority of an exper...
Abstract Background Clinical trials often seek to determine the superiority, equivalence, or non-inf...
BACKGROUND: In clinical trials, study designs may focus on assessment of superiority, equivalence, o...
Non-inferiority trials, which aim to demonstrate that a test product is not worse than a competitor ...
Medical research makes intensive use of statistics in order to support its claims. In this paper we ...
In this article, we consider three-arm noninferiority (NI) trial that includes an experimental, a re...
In non-inferiority trials, the goal is to show how an experimental treatment is statistically and cl...
Background and aims: It has been proposed that more use should be made of Bayes factors in hypothesi...
Inference using significance testing and Bayes factors is compared and contrasted in five case studi...
BackgroundUntil recently a typical rule that has often been used for the endorsement of new medicati...
In frequentist tests, the significance testing framework for null hypothesis permits dichotomous con...
This perspective is a companion to a recent editorial on the use of Bayesian analysis in clinical re...
There have been considerable methodological developments of Bayes factors for hypothesis testing in ...
RATIONALEBedside use of Bayes' theorem for estimating probabilities of diseases is cumbersome. An al...